Compare TGNA & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGNA | PBH |
|---|---|---|
| Founded | 1906 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.9B |
| IPO Year | N/A | 2005 |
| Metric | TGNA | PBH |
|---|---|---|
| Price | $18.91 | $64.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $20.00 | ★ $86.40 |
| AVG Volume (30 Days) | ★ 1.1M | 347.1K |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.10 | ★ 4.04 |
| Revenue | ★ $2,876,414,000.00 | $1,110,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.10 | $2.50 |
| P/E Ratio | ★ $8.98 | $15.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.87 | $57.25 |
| 52 Week High | $21.35 | $90.04 |
| Indicator | TGNA | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 41.41 | 50.74 |
| Support Level | $18.80 | $62.73 |
| Resistance Level | $19.00 | $68.28 |
| Average True Range (ATR) | 0.23 | 1.67 |
| MACD | 0.02 | -0.30 |
| Stochastic Oscillator | 26.34 | 24.50 |
Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.